Fampridine Other names: 4-Aminopyridine 4-AP Dalfampridine

Chemical formula: Câ‚…H₆Nâ‚‚  Molecular mass: 94.115 g/mol  PubChem compound: 1727

Therapeutic indications

Fampridine is indicated for:

Multiple sclerosis with walking disability

Population group: only adults (18 - 65 years old)

Fampridine is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (EDSS 4-7).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Fampridine is contraindicated in the following cases:

Organic Cation Transporter 2 (OCT2) inhibitors

Inhibitors of organic cation transporters 2

Renal impairment

Renal failure

Seizure

Seizure

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: FAMPYRA Prolonged-release tablets
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈